Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $806,589 - $918,261
3,585 Added 7.24%
53,123 $12.7 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $566,049 - $653,997
2,361 Added 5.0%
49,538 $12.5 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $9.59 Million - $11.2 Million
39,710 Added 531.81%
47,177 $12.5 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $543,284 - $3.31 Million
-2,199 Reduced 22.75%
7,467 $1.68 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $996,099 - $1.26 Million
4,201 Added 76.87%
9,666 $2.46 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $132,751 - $162,932
-516 Reduced 8.63%
5,465 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $149,252 - $168,124
511 Added 9.34%
5,981 $1.97 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $141,821 - $173,196
521 Added 10.53%
5,470 $1.67 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $244,211 - $294,783
1,085 Added 28.08%
4,949 $1.33 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $124,029 - $143,605
584 Added 17.8%
3,864 $870,000
Q4 2020

Feb 08, 2021

SELL
$212.5 - $245.46 $2,975 - $3,436
-14 Reduced 0.43%
3,280 $729,000
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $25,156 - $30,576
-142 Reduced 4.13%
3,294 $710,000
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $2.88 Million - $3.96 Million
-22,402 Reduced 86.7%
3,436 $608,000
Q2 2020

Jul 17, 2020

BUY
$128.7 - $176.83 $3.05 Million - $4.19 Million
23,669 Added 1091.24%
25,838 $4.57 Million
Q1 2020

May 12, 2020

SELL
$121.39 - $169.05 $42,000 - $58,491
-346 Reduced 13.76%
2,169 $301,000
Q4 2019

Feb 11, 2020

SELL
$133.47 - $153.48 $39,373 - $45,276
-295 Reduced 10.5%
2,515 $386,000
Q3 2019

Nov 13, 2019

BUY
$135.4 - $146.47 $18,143 - $19,626
134 Added 5.01%
2,810 $406,000
Q2 2019

Aug 12, 2019

SELL
$124.88 - $143.73 $16,609 - $19,116
-133 Reduced 4.73%
2,676 $383,000
Q1 2019

May 08, 2019

SELL
$97.62 - $132.29 $142,915 - $193,672
-1,464 Reduced 34.26%
2,809 $371,000
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $76,069 - $87,851
802 Added 23.11%
4,273 $441,000
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $4,513 - $5,009
-46 Reduced 1.31%
3,471 $377,000
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $55,738 - $59,879
-580 Reduced 14.16%
3,517 $347,000
Q1 2018

May 14, 2018

SELL
$92.16 - $103.8 $21,934 - $24,704
-238 Reduced 5.49%
4,097 $413,000
Q4 2017

Feb 15, 2018

SELL
$85.26 - $94.62 $44,420 - $49,297
-521 Reduced 10.73%
4,335 $402,000
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $385,032 - $429,513
4,856
4,856 $417,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.